|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
13,380,000 |
Market
Cap: |
196.82(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$11.6 - $15 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : 16.2 |
Insider 3/6 Months : 16.8 |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Merrimack Pharmaceuticals is a biopharmaceutical company. Co. does not have any ongoing research or development activities.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
278,500 |
504,050 |
1,194,261 |
Total Buy Value |
$0 |
$3,532,303 |
$6,240,948 |
$13,669,512 |
Total People Bought |
0 |
1 |
2 |
4 |
Total Buy Transactions |
0 |
9 |
13 |
46 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-01-25 |
2023-10-24 |
2023-04-25 |
2022-04-25 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Western Standard Partners Qp, L.p. |
See Remarks |
|
2023-12-28 |
4 |
B |
$13.35 |
$11,441 |
I/I |
857 |
534,008 |
0.01 |
11% |
|
Western Standard Partners Qp, L.p. |
See Remarks |
|
2023-12-26 |
4 |
B |
$13.15 |
$640,313 |
I/I |
48,693 |
533,151 |
0.01 |
11% |
|
Western Standard Partners Qp, L.p. |
See Remarks |
|
2023-12-07 |
4 |
B |
$12.85 |
$1,298,472 |
I/I |
101,050 |
484,458 |
0.01 |
14% |
|
Western Standard Partners Qp, L.p. |
See Remarks |
|
2023-11-17 |
4 |
B |
$12.50 |
$3,750 |
I/I |
300 |
459,792 |
0.01 |
15% |
|
Western Standard Partners Qp, L.p. |
See Remarks |
|
2023-11-14 |
4 |
B |
$12.50 |
$627,125 |
I/I |
50,170 |
459,727 |
0.01 |
17% |
|
Western Standard Partners Qp, L.p. |
See Remarks |
|
2023-11-13 |
4 |
B |
$12.39 |
$192,875 |
I/I |
15,570 |
448,840 |
0.01 |
19% |
|
Western Standard Partners Qp, L.p. |
See Remarks |
|
2023-11-10 |
4 |
B |
$12.32 |
$469,008 |
I/I |
38,062 |
445,461 |
0.01 |
19% |
|
Western Standard Partners Qp, L.p. |
See Remarks |
|
2023-11-09 |
4 |
B |
$12.19 |
$121,618 |
I/I |
9,975 |
437,202 |
0.01 |
20% |
|
Western Standard Partners Qp, L.p. |
See Remarks |
|
2023-11-08 |
4 |
B |
$12.13 |
$167,701 |
I/I |
13,823 |
435,037 |
0.01 |
20% |
|
Crocker Gary L |
See Remarks |
|
2023-08-11 |
4 |
B |
$12.43 |
$24,865 |
I/I |
2,000 |
133,105 |
0.01 |
6% |
|
Crocker Gary L |
See Remarks |
|
2023-08-10 |
4 |
B |
$12.52 |
$25,039 |
I/I |
2,000 |
133,105 |
0.01 |
5% |
|
Western Standard Partners Qp, L.p. |
See Remarks |
|
2023-08-08 |
4 |
B |
$12.00 |
$1,044,327 |
I/I |
87,057 |
425,997 |
0.01 |
8% |
|
Western Standard Partners Qp, L.p. |
See Remarks |
|
2023-08-07 |
4 |
B |
$12.00 |
$1,614,414 |
I/I |
134,493 |
407,371 |
0.01 |
10% |
|
Western Standard Partners Qp, L.p. |
See Remarks |
|
2023-03-21 |
4 |
B |
$11.52 |
$1,849,997 |
I/I |
160,590 |
357,514 |
0.01 |
4% |
|
Western Standard Partners Qp, L.p. |
See Remarks |
|
2023-01-31 |
4/A |
B |
$11.40 |
$25,444 |
I/I |
2,232 |
324,333 |
0.01 |
- |
|
Western Standard Partners Qp, L.p. |
See Remarks |
|
2023-01-31 |
4 |
B |
$11.40 |
$25,444 |
I/I |
2,232 |
324,306 |
0.01 |
8% |
|
Western Standard Partners Qp, L.p. |
See Remarks |
|
2023-01-30 |
4/A |
B |
$11.36 |
$280,930 |
I/I |
24,735 |
323,883 |
0.01 |
- |
|
Western Standard Partners Qp, L.p. |
See Remarks |
|
2023-01-30 |
4 |
B |
$11.36 |
$280,624 |
I/I |
24,708 |
323,856 |
0.01 |
9% |
|
Western Standard Partners Qp, L.p. |
See Remarks |
|
2023-01-27 |
4 |
B |
$11.40 |
$249,298 |
I/I |
21,875 |
318,898 |
0.01 |
9% |
|
Ledo Capital, Llc |
See Remarks |
|
2023-01-12 |
4 |
B |
$11.90 |
$1,190,000 |
I/I |
100,000 |
1,119,586 |
0.01 |
1% |
|
Radeljevic Ana |
Director |
|
2023-01-06 |
4 |
B |
$12.03 |
$49,997 |
D/D |
4,156 |
4,156 |
2.39 |
7% |
|
Western Standard Partners Qp, L.p. |
See Remarks |
|
2023-01-03 |
4 |
B |
$11.33 |
$347,159 |
I/I |
30,632 |
314,488 |
0.01 |
7% |
|
Ledo Capital, Llc |
See Remarks |
|
2023-01-03 |
4 |
B |
$11.24 |
$59,564 |
I/I |
5,300 |
1,019,586 |
0.01 |
7% |
|
Ledo Capital, Llc |
See Remarks |
|
2022-12-30 |
4 |
B |
$11.24 |
$14,615 |
I/I |
1,300 |
1,014,286 |
0.01 |
9% |
|
Western Standard Partners Qp, L.p. |
See Remarks |
|
2022-12-30 |
4 |
B |
$11.33 |
$468,041 |
I/I |
41,300 |
306,269 |
0.01 |
9% |
|
410 Records found
|
|
Page 1 of 17 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|